These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 37283735)
1. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach. Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T Front Immunol; 2023; 14():1175535. PubMed ID: 37283735 [TBL] [Abstract][Full Text] [Related]
2. Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach. Naseer F; Ahmad T; Kousar K; Kakar S; Gul R; Anjum S; Shareef U Int J Nanomedicine; 2023; 18():185-205. PubMed ID: 36643861 [TBL] [Abstract][Full Text] [Related]
3. Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma. Kousar K; Naseer F; Abduh MS; Kakar S; Gul R; Anjum S; Ahmad T Front Pharmacol; 2022; 13():1073004. PubMed ID: 36712656 [TBL] [Abstract][Full Text] [Related]
4. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer. Abduh MS Int J Nanomedicine; 2023; 18():5713-5732. PubMed ID: 37849642 [TBL] [Abstract][Full Text] [Related]
5. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine. Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628 [TBL] [Abstract][Full Text] [Related]
6. Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach. Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T Front Immunol; 2024; 15():1391710. PubMed ID: 38529281 [TBL] [Abstract][Full Text] [Related]
7. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer. Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930 [TBL] [Abstract][Full Text] [Related]
8. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles. Zhao K; Chen G; Shi XM; Gao TT; Li W; Zhao Y; Zhang FQ; Wu J; Cui X; Wang YF PLoS One; 2012; 7(12):e53314. PubMed ID: 23285276 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy. Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488 [TBL] [Abstract][Full Text] [Related]
10. Exploration of the Delivery of Oncolytic Newcastle Disease Virus by Gelatin Methacryloyl Microneedles. Zhang Q; Na J; Liu X; He J Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397030 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro-chemotherapeutic approach. Anjum S; Naseer F; Ahmad T; Liaquat A; Abduh MS; Kousar K J Med Virol; 2024 Jul; 96(7):e29748. PubMed ID: 38975633 [TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine. Zhao K; Sun Y; Chen G; Rong G; Kang H; Jin Z; Wang X Carbohydr Polym; 2016 Sep; 149():28-39. PubMed ID: 27261727 [TBL] [Abstract][Full Text] [Related]
13. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats. Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103 [TBL] [Abstract][Full Text] [Related]
14. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways. Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Keshavarz M; Alikhani MY; Ghaemi A Microb Pathog; 2020 Oct; 147():104438. PubMed ID: 32777353 [TBL] [Abstract][Full Text] [Related]
15. Chitosan and chitosan/PEG nanoparticles loaded with indole-3-carbinol: Characterization, computational study and potential effect on human bladder cancer cells. Melo MN; Pereira FM; Rocha MA; Ribeiro JG; Junges A; Monteiro WF; Diz FM; Ligabue RA; Morrone FB; Severino P; Fricks AT Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112089. PubMed ID: 33947529 [TBL] [Abstract][Full Text] [Related]
16. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132. Mehrotra A; Nagarwal RC; Pandit JK Chem Pharm Bull (Tokyo); 2011; 59(3):315-20. PubMed ID: 21372411 [TBL] [Abstract][Full Text] [Related]
17. Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells. Golalipour A; Mohammadi A; Hosseinzadeh S; Soltani A; Erfani-Moghadam V PLoS One; 2024; 19(8):e0308599. PubMed ID: 39141643 [TBL] [Abstract][Full Text] [Related]
18. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine. Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070 [TBL] [Abstract][Full Text] [Related]
19. In ovo delivery of Newcastle disease virus conjugated hybrid calcium phosphate nanoparticle and to study the cytokine profile induction. Viswanathan K; Rathish P; Gopinath VP; Janice R; Raj GD Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():564-72. PubMed ID: 25491865 [TBL] [Abstract][Full Text] [Related]
20. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment. Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A Virol J; 2020 May; 17(1):64. PubMed ID: 32370750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]